Abiopharma

🔍 Dewan Darryll E (Executive)

Company: TSS, Inc. (TSSI)

Report Date: 2026-03-23-05:00

Detailed Transactions and Holdings:

• Acquired 5,000 shares of Common Stock (Direct)
  Date: 2026-03-23-05:00 | Code: A | equity_swap_involved: false | shares_owned_after: 604,471.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-23-05:00 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 5,000.00

Footnotes:

• F1: These shares of common stock represent restricted stock granted to Mr. Dewan that are subject to financial performance vesting criteria that has been achieved. The restricted stock vests in installments as follows assuming Mr. Dewan remains employed through the applicable vesting dates: (1) 2,500 shares vested on March 23, 2026, and (2) 2,500 shares will vest on January 1, 2027, and are subject to forfeiture.
• REMARKS: (1) These shares of common stock represent restricted stock granted to Mr. Dewan that are subject to financial performance vesting criteria that has been achieved. The restricted stock vests in installments as follows assuming Mr. Dewan remains employed through the applicable vesting dates: (1) 2,500 shares vested on March 23, 2026, and (2) 2,500 shares will vest on January 1, 2027, and are subject to forfeiture.